US Patent Issued to INFEX Therapeutics on Feb. 10 for "1-aminosulfonyl-2-carboxypyrrole derivatives as metallo-beta-lactamase inhibitors" (British, Swedish Inventors)

ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,544,359, issued on Feb. 10, was assigned to INFEX Therapeutics Ltd. (Macclesfield, Great Britain).

"1-aminosulfonyl-2-carboxypyrrole derivatives as metallo-beta-lactamase inhibitors" was invented by Andrew Wilkinson (Macclesfield, Great Britain), Ian Cooper (Macclesfield, Great Britain), David Orr (Macclesfield, Great Britain), Jonathan Finlayson (Macclesfield, Great Britain), Adam Bunt (Macclesfield, Great Britain), Pia Appelqvist (Huddinge, Sweden), Hans Wallberg (Huddinge, Sweden), Fredrik Wangsell (Molndal, Sweden) and James Kirkham (Cheshire, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention relates to compounds of formula...